Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 35 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT02945579
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
- Locations
-
- MD Anderson Cancer Center - Banner Gilbert, Arizona, United States
- Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
- Queen's Medical Center Honolulu, Hawaii, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01750073
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +20 more
- Locations
-
- Nebraska Medicine-Bellevue Bellevue, Nebraska, United States
- CHI Health Saint Francis Grand Island, Nebraska, United States
- Nebraska Medicine-Village Pointe Cancer Center Omaha, Nebraska, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT00785291
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +12 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Sparks Regional Medical Center Fort Smith, Arkansas, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
- NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
NCT03213041
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +11 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT03715959
- Conditions
- Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, +32 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT03154190
- Conditions
- Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +146 more
- Locations
-
- Virginia K Crosson Cancer Center Fullerton, California, United States
NCT02648477
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +11 more
- Locations
-
- City of Hope Corona Corona, California, United States
- City of Hope Medical Center Duarte, California, United States
- City of Hope Antelope Valley Lancaster, California, United States
- City of Hope Rancho Cucamonga Rancho Cucamonga, California, United States
NCT02971761
- Conditions
- Androgen Receptor Positive, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- City of Hope Corona Corona, California, United States
- City of Hope Medical Center Duarte, California, United States
- City of Hope Antelope Valley Lancaster, California, United States
- City of Hope Mission Hills Mission Hills, California, United States
NCT02672475
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +10 more
- Locations
-
- Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
NCT04081389
- Conditions
- Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, +28 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT03599453
- Conditions
- Anatomic Stage IV Breast Cancer AJCC, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01846091
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +21 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
NCT02120469
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +9 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope Rancho Cucamonga Rancho Cucamonga, California, United States
- South Pasadena Cancer Center South Pasadena, California, United States
MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer
NCT02536794
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +8 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Northwestern University- Lake Forest Hospital Lake Forest, Illinois, United States
Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
NCT03106077
- Conditions
- Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
IACS-010759 in Advanced Cancers
NCT03291938
- Conditions
- Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer
NCT03544125
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT01753908
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +25 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01964924
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +11 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
NCT02599194
- Conditions
- Adenocarcinoma, Adenoma, B-Cell Neoplasm, +53 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States